1. Yan, Guang, Zhu, Tianhang, Zhou, Jiawei, Shi, Xiaojun, Tan, Wanlong. . GOLM1 promotes prostate cancer progression via interaction with PSMD1 and enhancing AR-driven transcriptional activation. In Journal of cellular and molecular medicine, 28, e70186. doi:10.1111/jcmm.70186. https://pubmed.ncbi.nlm.nih.gov/39470578/
2. Teerlink, Craig C, Huff, Chad, Stevens, Jeff, Leachman, Sancy, Cannon-Albright, Lisa A. . A Nonsynonymous Variant in the GOLM1 Gene in Cutaneous Malignant Melanoma. In Journal of the National Cancer Institute, 110, 1380-1385. doi:10.1093/jnci/djy058. https://pubmed.ncbi.nlm.nih.gov/29659923/
3. Ye, Qing-Hai, Zhu, Wen-Wei, Zhang, Ju-Bo, Wang, Xin Wei, Qin, Lun-Xiu. 2016. GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis. In Cancer cell, 30, 444-458. doi:10.1016/j.ccell.2016.07.017. https://pubmed.ncbi.nlm.nih.gov/27569582/
4. Guan, Junhua, Qin, Yunpeng, Deng, Guiyuan, Zhao, Haihong. 2022. GOLM1 as a Potential Therapeutic Target Modulates B7-H3 Secretion to Drive Ovarian Cancer Metastasis. In Evidence-based complementary and alternative medicine : eCAM, 2022, 5151065. doi:10.1155/2022/5151065. https://pubmed.ncbi.nlm.nih.gov/35116068/
5. Mao, Zonglei, Wu, Yong, Yao, Pingan, Xing, Chungen. . GOLM1 facilitates human colorectal cancer progression and metastasis via activating the AKT/GSK3β/EMT axis. In Neoplasma, 70, 136-144. doi:10.4149/neo_2023_220816N835. https://pubmed.ncbi.nlm.nih.gov/36916929/
6. Liang, Xin, Yin, Yu, Li, Ning. 2022. GOLM1 is related to the inflammatory/immune nature of uveal melanoma and acts as a promising indicator for prognosis and immunotherapy response. In Frontiers in genetics, 13, 1051168. doi:10.3389/fgene.2022.1051168. https://pubmed.ncbi.nlm.nih.gov/36468024/
7. Xi, Yue, Zhang, Tiange, Sun, Wei, Ganesh, Sridha, Chen, Honglei. 2022. GOLM1 and FAM49B: Potential Biomarkers in HNSCC Based on Bioinformatics and Immunohistochemical Analysis. In International journal of molecular sciences, 23, . doi:10.3390/ijms232315433. https://pubmed.ncbi.nlm.nih.gov/36499755/
8. Lin, Yan, He, Ziqin, Gao, Xing, Ye, Jiazhou, Liang, Rong. 2022. Integrative Analysis Reveals the Potential Role and Prognostic Value of GOLM1 in Hepatocellular Carcinoma. In Oxidative medicine and cellular longevity, 2022, 8284500. doi:10.1155/2022/8284500. https://pubmed.ncbi.nlm.nih.gov/36211823/
9. Gai, Xiaochen, Tang, Bufu, Liu, Fangming, Wang, Ling, Zhang, Hongbing. 2019. mTOR/miR-145-regulated exosomal GOLM1 promotes hepatocellular carcinoma through augmented GSK-3β/MMPs. In Journal of genetics and genomics = Yi chuan xue bao, 46, 235-245. doi:10.1016/j.jgg.2019.03.013. https://pubmed.ncbi.nlm.nih.gov/31186161/
10. Ding, Xiang, Deng, Gang, Liu, Junhui, Yang, Xue, Chen, Qianxue. 2019. GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt/β-catenin signaling pathway. In Brain research, 1717, 117-126. doi:10.1016/j.brainres.2019.03.035. https://pubmed.ncbi.nlm.nih.gov/30935831/